Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Monte Rosa Therapeutics Stock (NASDAQ: GLUE) stock price, news, charts, stock research, profile.

Open	$5.79
Close	$5.66
Volume / Avg.	631.11K / 2.81M
Day Range	$5.55 - $5.91
52 Wk Range	3.21 - 12.40
Market Cap	$347.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	27.19%
Days to Cover	6.89

Recent News

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Why Is Monte Rosa Therapeutics Stock Surging On Monday?

Monte Rosa Therapeutics stock rises as it announces a global licensing deal with Novartis to advance MRT-6160 for immune conditions.

Vandana Singh

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.79
Close	$5.66
Volume / Avg.	631.11K / 2.81M
Day Range	$5.55 - $5.91
52 Wk Range	3.21 - 12.40
Market Cap	$347.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	27.19%
Days to Cover	6.89

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Monte Rosa Therapeutics (GLUE) stock?

You can purchase shares of Monte Rosa Therapeutics (NASDAQ:GLUE) through any online brokerage.

View our list of the best stock brokerages

Who are Monte Rosa Therapeutics (GLUE) competitors?

Other companies in Monte Rosa Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).

What is the forecast, or price target, for Monte Rosa Therapeutics (GLUE) stock?

Monte Rosa Therapeutics has a consensus price target of $14.57.

What is the current price for Monte Rosa Therapeutics (GLUE)?

The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $5.655 last updated January 17, 2025 at 4:00 PM EST.

Does Monte Rosa Therapeutics (GLUE) pay a dividend?

There are no upcoming dividends for Monte Rosa Therapeutics.

When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?

Monte Rosa Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.

Is Monte Rosa Therapeutics (GLUE) going to split?

There is no upcoming split for Monte Rosa Therapeutics.

What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?

Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Monte Rosa Therapeutics

Monte Rosa Therapeutics (GLUE) Forecast